Login
Manage Portfolio
Post a StockTalk
Write an Instablog
Get Daily Email Alert
Seeking Alpha
Home
The Macro View
Stocks & Sectors
Global Markets
ETFs
Investing Ideas
Breaking News
Transcripts
Business Intelligence
GenVec Inc. (GNVC)
(
)
Quotes
Dashboard
Chart
Historical Prices
Options
Analysis
Articles
Instablogs
StockTalks
Sentiment
Comments
News & PR
Market Currents
Buzz
Twitter: GNVC
Coverage
Top Authors
Cramer
Top Analysts
Business Intelligence
Transcripts
Events
Key Developments
Earnings
History & Projected
Consensus
Peer Earnings
Filings
SEC Filings
Annual Report
Ownership
Major Holders
Insider Trades
Insider Sentiment
Index Membership
Short Interest
Financials
Income Statement
Balance Sheet
Cash Flow
Company
Wikipedia Profile
Officers & Directors
Executive Comp
Analysis - Latest Articles
by
most recent
|
most commented
Closing Update for Thursday, Sept. 24: Nasdaq, Oil Lead the Decline
Sep 24, 2009
•
Midnight Trader
•
1 Comment
Readers Ask: Antares, GenVec, Xoma,
Sep 13, 2009
•
VFC's Stock House
•
12 Comments
Closing Update for Tuesday, August 25: Dow Makes It Six Straight Gains
Aug 25, 2009
•
Midnight Trader
•
9 Comments
Extreme FDA Trades: 30 Stocks Under 5 Bucks
Aug 2, 2009
•
Mike Havrilla
•
22 Comments
Extreme FDA Trades: Another 18 Stocks Under 5 Bucks
Jul 5, 2009
•
Mike Havrilla
•
2 Comments
GenVec, Inc.: The Biggest Little Biotech
Jan 18, 2008
•
Beta Delta
•
4 Comments
Keep Your Eye on GenVec - But Your Money Elsewhere
Nov 16, 2007
•
Rocco Fenton
•
2 Comments
Has Gene Therapy Finally Come of Age?
Jul 3, 2007
•
Mebane Faber
•
2 Comments
Cancer Stocks Hammered Once Again
Jun 26, 2007
•
Alan Brochstein
•
7 Comments
Cancer Stocks Slide Again
Jun 18, 2007
•
Alan Brochstein
•
1 Comment
Cancer Stocks Plunge Following ASCO Meeting
Jun 11, 2007
•
Alan Brochstein
•
3 Comments
Cancer Stocks Soar With Annual ASCO Meeting
Jun 4, 2007
•
Alan Brochstein
•
1 Comment
Cancer Stocks on the Go: Winners and Losers
May 29, 2007
•
Alan Brochstein
•
3 Comments
Biotech Stocks: InterMune Retrenches
Mar 22, 2007
•
Centient Biotech Investor
•
Comment!
Biotech Day In Review: InterMune Scaling Back Operations, MGI's Positive Trial
Mar 21, 2007
•
Comment!
Biotech Day in Review: ImClone Chooses to Go It Alone
Feb 7, 2007
•
Centient Biotech Investor
•
Comment!
Biotech Day in Review: AstraZeneca Buys Arrow Therapeutics
Feb 2, 2007
•
Centient Biotech Investor
•
Comment!
Biotech Stocks Day-In-Review: Amgen Drags Biotech Lower
Jan 28, 2007
•
Centient Biotech Investor
•
Comment!
Biotech Stocks Day-in-Review: Lilly Drug Effective In Pancreatic Cancer
Jan 18, 2007
•
Centient Biotech Investor
•
Comment!
Bristol-Myers Squibb Partners with AstraZeneca in $1.2 Billion Pact
Jan 12, 2007
•
Centient Biotech Investor
•
Comment!
Biotech IPO: BioVex Group Files S-1 (BVEX)
Jun 25, 2006
•
SA Editor Abbi Adest
•
Comment!